HomeTechnology

Technology

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026

biotech

KTU chemists develop dual-action compounds to fight cancer

Jim Cornall - August 20, 2026

biotech

RSV antiviral drug receives FDA approval for phase II trial

Jim Cornall - August 20, 2026

biotech

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

Jim Cornall - August 19, 2026

computing

Better cybersecurity with new material

Jim Cornall - September 6, 2023

automation

How automation protects food and beverage workers from the dangers of palletising

Jim Cornall - August 2, 2023

research

Diamonds are a counterfeiter’s worst friend

Jim Cornall - August 1, 2023

biotech

10 Lithuanian startups to watch

Jim Cornall - July 30, 2023

Technology

Could light be the future of the internet and data transmission?

Jim Cornall - July 25, 2023

Technology

From chaos to light

Jim Cornall - July 20, 2023

Technology

Israel Innovation Authority investing in R&D center for bio-chips-based bio-devices

Jim Cornall - July 18, 2023

1...6 78Page 8 of 8

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026 0

This week, we have a conversation about the Flexible Automation for Scalable Health (FLASH) programme, focused on the development of scalable cell-free DNA bioproduction...

KTU chemists develop dual-action compounds to fight cancer

biotech Jim Cornall - August 20, 2026 0

RSV antiviral drug receives FDA approval for phase II trial

biotech Jim Cornall - August 20, 2026 0

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

biotech Jim Cornall - August 19, 2026 0

Pilot project between BioCytics and LIDE Biotech

biotech Jim Cornall - August 19, 2026 0